In March 2025, the company introduced new strategies to get a immediate-to-consumer presenting of its Wegovy weight loss drug. The company recognized a brand new pharmacy, known as NovoCare, which would cost consumers $499 every month for use of the drug, below 50 % the expense of the drug through other pharmaceutical distribution networks.[fifty t